Sandbox2: Difference between revisions
No edit summary |
No edit summary |
||
Line 55: | Line 55: | ||
❑ Narrow QRS complexes <br> | ❑ Narrow QRS complexes <br> | ||
❑ Ventricular rate between 150-250 bpm (or more) usually regular <br> | ❑ Ventricular rate between 150-250 bpm (or more) usually regular <br> | ||
❑ Short PR interval less than one half of the tachycardia RR interval | ❑ Short PR interval less than one half of the tachycardia RR interval | ||
</div>| | </div>| | ||
D02=<div style="float: left; text-align: left;"> '''Antidromic AVRT''' <br> | D02=<div style="float: left; text-align: left;"> '''Antidromic AVRT''' <br> | ||
The impulse travels from the atrium to the ventricle through the | The impulse travels from the atrium to the ventricle through the AV node and returns to the atrium through the accesory pathway. 90-95% of [[WPW]] | ||
❑ Wide QRS complexes <br> | ❑ Wide QRS complexes <br> | ||
❑ Ventricular rate between 150-250 bpm (or more) usually regular <br> | ❑ Ventricular rate between 150-250 bpm (or more) usually regular <br> | ||
❑ Short PR interval more than one half of the tachycardia RR interval | ❑ Short PR interval more than one half of the tachycardia RR interval | ||
<div>}} | </div>}} |
Revision as of 18:36, 14 March 2014
|
Overview
Wolff-Parkinson-White syndrome (WPW) is a syndrome of pre-excitation of the ventricles of the heart due to an accessory pathway known as the Bundle of Kent.
Causes
Life Threatening Causes
Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated. Wolff-Parkinson-White syndrome can be a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
WPW is a congenic disease
Managment
Initial Management
Shown below is an algorithm summarizing the initial management of supraventricular tachycardia according to the 2003 ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias.[1]
- ↑ "ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary". Retrieved 15 August 2013.
Characterize the symptoms:
Characterize the timing of the symptoms: | |||||||||||||||||||||||||||||||||||||||
Identify possible triggers: | |||||||||||||||||||||||||||||||||||||||
❑ Examine the patient
❑ Order and monitor the ECG | |||||||||||||||||||||||||||||||||||||||
❑ Assess the ECG | |||||||||||||||||||||||||||||||||||||||
Orthodromic AVRT The impulse travels from the atrium to the ventricle through the AV node and returns to the atrium through the accesory pathway. 90-95% of WPW ❑ Narrow QRS complexes | Antidromic AVRT The impulse travels from the atrium to the ventricle through the AV node and returns to the atrium through the accesory pathway. 90-95% of WPW ❑ Wide QRS complexes | ||||||||||||||||||||||||||||||||||||||